Close
Veronica Richardson, MSN, ANP-BC, DCNP Bio
Veronica Richardson is a medical dermatology nurse practitioner at the University of Pennsylvania Department of Dermatology. She has been practicing as an APP in the field of medical dermatology since 2011. Prior entering the field of dermatology she practiced as an inpatient internal medicine/hospitalist NP for 4 years. She has a passion for educating APP’s and sharing her love of caring for dermatology patients. From 2017-2023 she served on the medical board of the National Psoriasis Foundation where she was chair of the APREP program- a program designed specifically for educating APPs about Psoriatic Disease. She currently serves on the leadership board for the Elevate Derm NP/PA educational conference and speaking faculty for the Center for Dermatology Nursing Practice review course. She is on the editorial review board for the Journal of Dermatology for NP’s and PA’s (JDNPPA).
Close
Philip Mease, MD, MACR Bio
Dr. Philip Mease is the past president and founding organizer of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), an international organization of over 1,000 rheumatology and dermatology researchers dedicated to research and education about psoriasis and psoriatic arthritis. Dr. Mease received his undergraduate and medical degrees from Stanford University. He completed his internal medicine residency and rheumatology fellowship at the University of Washington. He cares for patients, directs the rheumatology research division at Swedish Medical Center, and is a Clinical Professor of Medicine at the University of Washington in Seattle.
Dr. Mease’s research interests have included psoriatic arthritis (PsA) and spondyloarthritis (SpA), rheumatoid arthritis (RA), fibromyalgia (FM,) and osteoporosis. His work includes research on disease state, developing outcome measures, and determining the efficacy and safety of emerging therapies for these conditions. His seminal 2000 Lancet paper established the efficacy of anti-tumor necrosis factor therapy in PsA. He has authored over 350 journal articles, numerous abstracts, and book chapters. He is a prolific international speaker at academic congresses, grand rounds, and other educational activities for rheumatologists and dermatologists. He is considered a global key opinion leader, researcher, educator, and clinician regarding SpA, including ankylosing spondylitis (AS), non-radiographic spondyloarthritis (nr-axSpA), and psoriatic arthritis. He reviews Arthritis & Rheumatology, Arthritis Care & Research, Annals of the Rheumatic Diseases, The Journal of Rheumatology, Seminars in Arthritis and Rheumatism, and other rheumatology journals.
Close
Daniel Butler, MD Bio
Dr. Daniel C. Butler is the assistant dean of student affairs and an associate professor at the University of Arizona College of Medicine in Tucson. He directs the U of Arizona’s Inflammatory and Aging Skin Research Program. Dr. Butler's research interests focus on the presentation and treatment of skin disease in older adults. In this thread, he founded and leads international clinical and research groups evaluating best practices in this population. Dr Butler has active clinical trials focusing on pruritus and atopic dermatitis in older adults. Dr Butler graduated from the University of Arizona College of Medicine and completed his dermatology residency at Harvard Medical School. He continues to mentor students and trainees all over the country who are interested in skin diseases of the oldest generation.
